TelyRx Holdings Inc. (TSX:TELY)
Canada · Delayed Price · Currency is CAD | Market Cap | 129.45M |
| Revenue (ttm) | 97.58M +620.8% |
| Net Income | -18.89M |
| EPS | -0.92 |
| Shares Out | 48.85M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,050 |
| Open | 2.720 |
| Previous Close | 2.690 |
| Day's Range | 2.650 - 2.750 |
| 52-Week Range | 2.000 - 4.250 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 10, 2026 |
About TelyRx Holdings
TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company is based in Clearwater, Florida. [Read more]
Financial Performance
In 2025, TelyRx Holdings's revenue was $42.92 million, an increase of 350.27% compared to the previous year's $9.53 million. Losses were -$5.43 million, -59.76% less than in 2024.
Financial numbers in USD Financial StatementsNews
TelyRx Expands Women's Health Offerings with New Menopause Supplement
Partnership with women's health company SISTERLY broadens the options available alongside prescription treatments for women navigating perimenopause and menopause CLEARWATER, Fla., Oct. 7, 2026 /PRNew...
TelyRx Holdings Earnings Call Transcript: Q2 2026
Revenue grew 143% year-over-year to $22.7M, driven by repeat customers now making up nearly 70% of revenue. Investments in marketing, a new website, and expanded operations support future growth, with gross margin rising to 57% and record prescription volumes achieved.
TelyRx Holdings Earnings release: Q2 2026
TelyRx Holdings released its Q2 2026 earnings on August 10, 2026, summarizing the period's financial results.
TelyRx Holdings MD&A: Q2 2026
TelyRx Holdings filed a regulatory document on August 10, 2026 disclosing important business information.
TelyRx Holdings Report: Q2 2026
TelyRx Holdings published a report on August 10, 2026 containing material business information for investors and shareholders.
TelyRx Holdings Slides: Q2 2026
TelyRx Holdings has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 10, 2026.
TelyRx Launches New Brand and Digital Experience Inspired by Patient Feedback
New brand platform reflects patient demand for everyday healthcare that is simpler to access, while expanding its offering to more than 500 medications. CLEARWATER, Fla.
TelyRx to Host Second Quarter 2026 Financial Results Conference Call on Monday, August 10, 2026 at 8:30 am ET
Clearwater, Florida--(Newsfile Corp. - July 24, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy...
TelyRx Expands Operations in Clearwater, Fla., Tripling Footprint to Meet Growing Demand for Digital Healthcare
Expansion follows milestone of one million prescriptions filled CLEARWATER, Fla., July 14, 2026 /PRNewswire/ -- TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a digital h...
TelyRx Holdings Inc. Announces DTC Eligibility for U.S. Traded Shares
Clearwater, Florida--(Newsfile Corp. - July 10, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a digital healthcare and online pharmacy platform, today announced ...
TelyRx Holdings Transcript: Global Technology Virtual Investor Conference
A scalable, cash-pay pharmacy platform disrupts the $98B market by delivering 450+ medications quickly and transparently, achieving $43M annual revenue with strong repeat customer growth and expanding margins. Regulatory barriers protect its model, while tech and customer experience investments boost retention and lifetime value.
TelyRx to Present at the Global Technology Virtual Investor Conference July 9, 2026
Clearwater, Florida--(Newsfile Corp. - July 8, 2026) - Hot on the heels of its one million prescriptions filled milestone, TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), ...
TelyRx to Present at the Global Technology Virtual Investor Conference July 9th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as ...
TelyRx Announces Voting Results from Annual General Meeting of Shareholders
Clearwater, Florida--(Newsfile Corp. - June 15, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy...
TelyRx Surpasses 1 Million Prescriptions, Underscoring Growing Demand for Digital Pharmacy
Milestone reflects strong customer response to simpler, more convenient access to essential healthcare Clearwater, Florida--(Newsfile Corp. - June 8, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: T...
TelyRx Commences Trading on the OTCQX Market in the United States
Clearwater, Florida--(Newsfile Corp. - June 5, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy ...